TG Therapeutics Inc (NASDAQ:TGTX)
| 9.28 Delayed Data As of 4:00pm ET |  +2.16 / +30.34%Today’s Change | 3.32 Today|||52-Week Range 9.73 | +126.34% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 152.4K | 152.4K | 152.4K | 152.0K | |
| Depreciation And Amortization | 15.5K | 63.0K | 82.4K | 88.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 63.3M | 79.1M | 118.8M | 174.5M | ||
| Research And Development | 47.7M | 69.2M | 102.5M | 159.4M | ||
| Total Operating Expenses | 63.3M | 79.1M | 118.9M | 174.6M | ||
| Non-Operating Expenses | Operating Income | -63.2M | -79.0M | -118.7M | -174.4M | |
| Extraordinary Credit | 1.0M | 995.7K | 786.1K | 939.0K | ||
| Interest Expense On Debt | 972.7K | 886.1K | 0.00 | -- | ||
| Other Expenses | 0.00 | 283.5K | -844.8K | -878.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -62.9M | -78.3M | -118.5M | -173.5M | |
| Net Income | -62.9M | -78.3M | -118.5M | -173.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 45.6M | 49.0M | 62.1M | 75.5M | |
| Shares To Calculate EPS Diluted | 45.6M | 49.0M | 62.1M | 75.5M | ||
| Earnings Per Share | EPS | -$1.38 | -$1.60 | -$1.91 | -$2.30 | |
| EPS Diluted | -$1.38 | -$1.60 | -$1.91 | -$2.30 | ||
